Assessment of a Cationic Emulsion to Control the Tear Film Evaporation Rate

References

• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008
   PubMed Web of Science ®Google Scholar
• Willcox MD, Argüeso P, Georgiev GA, et al. TFOS DEWS II tear film report. Ocul Surf. 2017;15(3):366–403.
   PubMed Web of Science ®Google Scholar
• Korb DR, Association BCL. The tear film: structure, function, and clinical examination: butterworth-heinemann. 2002.
   Google Scholar
• McCulley JP, Shine WE. The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res. 2004;78(3):361–365. doi:10.1016/S0014-4835(03)00203-3
   PubMed Web of Science ®Google Scholar
• Agarwal P, Craig JP, Rupenthal ID. Formulation considerations for the management of dry eye disease. Pharmaceutics. 2021;13(2):207.
   PubMed Web of Science ®Google Scholar
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575–628.
   PubMed Web of Science ®Google Scholar
• Gagliano C, Papa V, Amato R, Malaguarnera G, Avitabile T. Measurement of the retention time of different ophthalmic formulations with ultrahigh-resolution optical coherence tomography. Curr Eye Res. 2018;43(4):499–502. doi:10.1080/02713683.2017.1418893
   PubMed Web of Science ®Google Scholar
• Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. Ophthalmology. 2000;107(5):967–974. doi:10.1016/S0161-6420(00)00035-X
   PubMed Web of Science ®Google Scholar
• Garrigue J-S, Amrane M, Faure M-O, Holopainen JM, Tong L. Relevance of lipid-based products in the management of dry eye disease. J Ocul Pharmacol Ther. 2017;33(9):647–661. doi:10.1089/jop.2017.0052
   PubMed Web of Science ®Google Scholar
• Khanal S, Tomlinson A, Pearce EI, Simmons PA. Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye. Cornea. 2007;26(2):175–181. doi:10.1097/ICO.0b013e31802b492d
   PubMed Web of Science ®Google Scholar
• Makri OE, Tsekouras I, Mastronikolis S, Georgakopoulos CD. Short-term effect of non-preserved cationic oil-in-water ophthalmic emulsion on tear meniscus parameters of healthy individuals in a prospective, controlled pilot study. Med Hypothesis Discovery Innovation Ophthalmol. 2021;10(1):5–10. doi:10.51329/mehdiophthal1415
   Google Scholar
• Napoli PE, Coronella F, Satta GM, Galantuomo MS, Fossarello M. Evaluation of the adhesive properties of the cornea by means of optical coherence tomography in patients with meibomian gland dysfunction and lacrimal tear deficiency. PLoS One. 2014;9(12):e115762. doi:10.1371/journal.pone.0115762
   PubMed Web of Science ®Google Scholar
• Napoli PE, Nioi M, d’Aloja E, Fossarello M. The bull’s eye pattern of the tear film in humans during visual fixation on en-face optical coherence tomography. Sci Rep. 2019;9(1):1–9. doi:10.1038/s41598-018-38260-5
   Web of Science ®Google Scholar
• Napoli PE, Coronella F, Satta GM, Fossarello M. A novel technique of contrast-enhanced optical coherence tomography imaging in evaluation of clearance of lipids in human tears. PLoS One. 2014;9(11):e109843. doi:10.1371/journal.pone.0109843
   PubMed Web of Science ®Google Scholar
• Lemp MA, Baudouin C, Baum J, et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the international Dry Eye workshop. Ocul Surf. 2007;5(2):75–92.
   PubMed Web of Science ®Google Scholar
• Best N, Drury L, Wolffsohn JS. Clinical evaluation of the Oculus Keratograph. Cont Lens Anterior Eye. 2012;35(4):171–174. doi:10.1016/j.clae.2012.04.002
   PubMed Web of Science ®Google Scholar
• Robert P-Y, Cochener B, Amrane M, et al. Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study. Eur J Ophthalmol. 2016;26(6):546–555. doi:10.5301/ejo.5000830
   PubMed Web of Science ®Google Scholar
• Lemp MA. Advances in understanding and managing dry eye disease. Am J Ophthalmol. 2008;146(3):350–356. doi:10.1016/j.ajo.2008.05.016
   PubMed Web of Science ®Google Scholar
• Mathers WD. Why the eye becomes dry: a cornea and lacrimal gland feedback model. CLAO j. 2000;26(3):159–165.
   Google Scholar
• McCann LC, Tomlinson A, Pearce EI, Papa V. Effectiveness of artificial tears in the management of evaporative dry eye. Cornea. 2012;31(1):1. doi:10.1097/ICO.0b013e31821b71e6
   PubMed Web of Science ®Google Scholar
• Daull P, Amrane M, Ismail D, et al. Cationic emulsion-based artificial tears as a mimic of functional healthy tear film for restoration of ocular surface homeostasis in dry eye disease. J Ocul Pharmacol Ther. 2020;36(6):355–365. doi:10.1089/jop.2020.0011
   PubMed Web of Science ®Google Scholar
• Pinheiro R, Panfil C, Schrage N, Dutescu RM. Comparison of the lubricant eyedrops Optive®, Vismed Multi®, and Cationorm® on the corneal healing process in an ex vivo model. Eur J Ophthalmol. 2015;25(5):379–384. doi:10.5301/ejo.5000593
   Web of Science ®Google Scholar
• Pearce EI, Tomlinson A, Blades KJ, Falkenberg HK, Lindsay B, Wilson CG. Effect of an oil and water emulsion on tear evaporation rate. Adv Exp Med Biol. 2002;506(A):419–424.
   Google Scholar
• Baudouin C, Galarreta DJ, Mrukwa-Kominek E, et al. Clinical evaluation of an oil-based lubricant eyedrop in dry eye patients with lipid deficiency. Eur J Ophthalmol. 2017;27(2):122–128. doi:10.5301/ejo.5000883
   PubMed Web of Science ®Google Scholar
• Jerkins G, Greiner JV, Tong L, et al. A comparison of efficacy and safety of two lipid-based lubricant eye drops for the management of evaporative dry eye disease. Clin Ophthalmol. 2020;14:1665. doi:10.2147/OPTH.S256351
   Web of Science ®Google Scholar
• Shine WE, McCulley JR. Polar lipids in human meibomian gland secretions. Curr Eye Res. 2003;26(2):89–94. doi:10.1076/ceyr.26.2.89.14515
   PubMed Web of Science ®Google Scholar
• Weisenberger K, Fogt N, Fogt JS. Comparison of nanoemulsion and non-emollient artificial tears on tear lipid layer thickness and symptoms. J Optom. 2021;14(1):20–27. doi:10.1016/j.optom.2020.03.002
   PubMedGoogle Scholar
• Muntz A, Marasini S, Wang MT, Craig JP. Prophylactic action of lipid and non-lipid tear supplements in adverse environmental conditions: a randomised crossover trial. Ocul Surf. 2020;18(4):920–925. doi:10.1016/j.jtos.2020.08.004
   Web of Science ®Google Scholar